...
首页> 外文期刊>IJC Heart & Vasculature >Relative diagnostic, prognostic and economic value of stress echocardiography versus exercise electrocardiography as initial investigation for the detection of coronary artery disease in patients with new onset suspected angina
【24h】

Relative diagnostic, prognostic and economic value of stress echocardiography versus exercise electrocardiography as initial investigation for the detection of coronary artery disease in patients with new onset suspected angina

机译:应力超声心动图与运动心电图的相对诊断,预后和经济价值,作为检测新发可疑心绞痛患者冠状动脉疾病的初步调查

获取原文
           

摘要

Objectives We hypothesised that stress echocardiography (SE), may be superior to exercise ECG (ExECG), for predicting CAD and outcome, and cost-beneficial, when performed as initial investigation in newly suspected angina. Methods All patients seen in 2011, with suspected angina, no history of CAD, pre-test likelihood of CAD of >10% and who underwent SE or ExECG as first line were identified retrospectively. Cost to diagnosis was calculated by adding the cost of all tests, up to and including coronary angiography (CA), on an intention-to-treat basis. Follow-up data on cardiac death and myocardial infarction (MI) were collected, 26months after the presentation of the last study patient. Results A total of 456 patients underwent ExECG (224 (49%) negative, 93 (20%) positive, 139 (31%) inconclusive) and 241 underwent SE (200 (83%) negative, 35 (15%) positive, 6 (2%) inconclusive) as first line. In patients subsequently undergoing CA, CAD was present in 46% (37/80) of patients with positive ExECG vs. 72% (23/32) patients with positive SE (p=0.01). Mean cost to diagnosis was £456 for the ExECG vs. £360 for the SE group (p=0.002). Over a mean follow-up period of 31±5months, cardiac events were 2% each in negative SE vs. negative ExECG (p=0.9). Conclusions SE is superior to ExECG for prediction of CAD and is cost-beneficial when used as initial test in patients with no history of CAD presenting with suspected angina.
机译:目的我们假设,对于新怀疑的心绞痛进行初步检查时,应力超声心动图(SE)在预测CAD和结局方面可能优于运动心电图(ExECG),并且具有成本效益。方法回顾性分析2011年就诊的所有疑似心绞痛,无CAD史,CAD检测前可能性> 10%,以SE或ExECG为一线患者。通过在意向性治疗的基础上,加上(包括)冠状动脉造影(CA)在内的所有测试的成本,计算出诊断成本。在最后一名研究患者就诊后26个月,收集了有关心脏死亡和心肌梗塞(MI)的随访数据。结果总共456例患者进行ExECG(224(49%)阴性,93(20%)阳性,139(31%)未定)和241例SEEC(200(83%)阴性,35(15%)阳性,6 (2%)不确定)作为第一行。在随后接受CA的患者中,CAD在ExECG阳性的患者中占46%(37/80),而SE阳性的患者中存在72%(23/32)(P = 0.01)。 ExECG的平均诊断成本为£ 456,而SE组为360(p = 0.002)。在平均随访时间31±5个月内,SE阴性与ExECG阴性的心脏事件各为2%(p = 0.9)。结论SE在预测CAD方面优于ExECG,并且在没有CAD历史可疑心绞痛的患者中用作初始测试时,具有成本效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号